 New York, New York--Newsfile Corp. - May 31, 2021 - The following statement is being issued by Levi Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of FibroGen, Inc. NASDAQ: FGEN FibroGen between October 18, 2017 and April 6, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina. To get more information go to: 